SAM
Senzar Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-506,900
| Closed | -$13.5M | – | 32 |
|
|
2016
Q3 | $13.5M | Buy |
506,900
+24,900
| +5% | +$663K | 3.49% | 8 |
|
|
2016
Q2 | $10.6M | Buy |
482,000
+143,149
| +42% | +$3.16M | 2.32% | 13 |
|
|
2016
Q1 | $9.95M | Buy |
338,851
+174,865
| +107% | +$5.14M | 1.98% | 18 |
|
|
2015
Q4 | $5.41M | Buy |
+163,986
| New | +$5.41M | 0.6% | 31 |
|
|
2015
Q2 | – | Sell |
-154,300
| Closed | -$4.73M | – | 40 |
|
|
2015
Q1 | $4.73M | Buy |
154,300
+110,183
| +250% | +$3.37M | 1.15% | 24 |
|
|
2014
Q4 | $2.24M | Sell |
44,117
-522,786
| -92% | -$26.6M | 0.66% | 32 |
|
|
2014
Q3 | $22.4M | Buy |
566,903
+311,775
| +122% | +$12.3M | 6.58% | 7 |
|
|
2014
Q2 | $11M | Buy |
255,128
+114,000
| +81% | +$4.91M | 4.2% | 10 |
|
|
2014
Q1 | $5.64M | Sell |
141,128
-19,343
| -12% | -$774K | 2.99% | 12 |
|
|
2013
Q4 | $4.38M | Buy |
+160,471
| New | +$4.38M | 3.58% | 13 |
|